Abstract
INTRODUCTION
This study examines trends in drug discovery. Drug discovery is an enormous
field, and this report focuses on a selection of the major workhorse
technologies, including liquid chromatography and mass spectrometry, as well
as on newer approaches, such as systems biology, high content screening, and
bioinformatics.
Trends in financing and business approaches are examined, as are strategies
for commercializing new products. The report also makes predictions about
technologies and approaches and how they are likely to perform in the next 5
years.
SCOPE OF STUDY
This report contains:
- Descriptions of various drug discovery-related products including
bioanalytical instruments, high throughput screening, informatics and
microarrays
- The current market status of drug discovery technologies, trends and
forecasts for growth over the next 5 years
- Discussion of new methods of research important to the market including
compound discovery, compound optimization, efficacy testing in vitro and in
vivo, toxicology testing, pharmacokinetics, and stability testing
- An analysis of patents and their importance to the industry.
METHODOLOGY AND INFORMATION SOURCES
The material for this report was gathered from interviews with individuals in
the industry, as well as a thorough review of technology gathered from
secondary sources. These sources include company annual, 10K and 10Q reports,
company literature, trade literature, trade associations, and online sources.
Note that the author of this report is herself involved in the development of
a compound for amyotrophic lateral sclerosis.
Projections were based on current and historical levels of funding and
revenues, potential end users, likely unit prices, and rates of consumption.
Final projections are based on the analysis of information from primary and
secondary sources. All dollar projections are presented in year 2007 constant
dollars.
View Cart
